Lawyers for the Lifecycle of Foods, Dietary Supplements, Cosmetics, Drugs & Medical Devices
Leading Trademark Lawyer Re-Joins Amin Talati Wasserman
Ryan Kaiser Returns To National Boutique to Expand Its Brand Protection Practice CHICAGO August 30, 2022 — Amin Talati Wasserman is thrilled to announce that Ryan Kaiser has joined the firm as partner. Mr. Kaiser, MORE >
see all news >Food, Beverage, Dietary Supplement & Cosmetic Compliance
We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness.
MOREIntellectual Property Protection
Drawing heavily on our IP, patent, trade secret, and trademark expertise, we provide our clients with business advice and strategies that enhance product value and prevent future litigation.
MORETrial Practice, Litigation & Dispute Resolution
We have a strong track record in disputes related to FDA, FTC, Proposition 65, consumer false advertising class actions, patent & trademark infringement, supply chain, technology, software, e-commerce and breach of contract claims.
MOREMedical Device & Drug Compliance
We provide strategic advice to clients from the inception of their drug and device products with a focus on enhancing product value, gaining regulatory approvals, and ensuring compliance.
MORE-
news
Online Webinar Now Available: “Advertising to an Aging Population”
Seniors are a powerful consumer demographic who want advertising they can believe and content backed by evidence. In their session, Advertising to an Aging Population, featured as part of the recent online series, “Active Aging: Mastering the Market” by Naturally Informed, ATW partners Lauren Aronson and Matt Orr explained the key ingredients companies need to […]
-
news
Abhishek Gurnani quoted in “FDA warning letters target claims to treat cardiovascular disease with supplements” – Natural Products Insider
Abhishek Gurnani spoke with Natural Products Insider about FDA’s warning to companies that sell dietary supplements claiming to cure, mitigate, treat or prevent cardiovascular disease. Abhishek commented: “There is a role for dietary supplements to support cardiovascular health, and there are certainly a number of dietary ingredients that have been studied for their ability to […]
-
news
Ivan Wasserman quoted in “FDA’s take down of NMN raises fairness, transparency concerns” – Nutraingredients – USA
Ivan Wasserman discussed the FDA’s recent decision that NMN is not a lawful dietary ingredient with Nutraingredients-USA. As reported, the development further complicates the decision to develop an NDI dossier and is part of an increasingly hard line stance by the Agency on the drug exclusion question. Ivan commented: “First CBD, then NAC, and now […]
